Advances in Oxidoreductases
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Antioxidant Enzyme Systems".
Deadline for manuscript submissions: 10 March 2026 | Viewed by 1125
Special Issue Editor
Interests: methionine oxidation; methionine restriction; aging; methionine sulfoxide reductase; redox biosensors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Oxidoreductases are enzymes that catalyze redox reactions, playing vital roles in metabolism, signaling, disease regulation, redox balance, tumor microenvironment modulation, and inflammation. Recent advancements in oxidoreductase research have greatly influenced fields like cancer therapy, immunology, and drug development, expanding our understanding of their involvement in cancer, inflammation, and metabolic disorders. Targeting specific oxidoreductases—such as MsrB1, TrxR, and NOX—holds promising potential for developing novel therapeutic strategies.
Despite our long-term study of oxidoreductases, they continue to reveal new functions and roles. Additionally, advancements in engineering technologies have facilitated their integration into innovative fields such as biosensors, expanding their research applications. This Special Issue aims to provide a platform for discussing and reviewing the latest research findings and developments in oxidoreductase-related studies.
We invite you to submit your latest research or a review article to this Special Issue, focusing on the function, regulation, and therapeutic potential of oxidoreductases, as well as their applications in fields such as redox biology, disease management, drug development, and biosensor technology.
Dr. Byung Cheon Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oxidoreductase
- redox enzyme
- metabolic regulation
- signaling
- cancer
- immune regulation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
